Cellebrite DI Ltd.
CLBT
$15.81
-$0.19-1.19%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | |||
|---|---|---|---|---|---|
| Net Income | 66.64% | -387.28% | -325.34% | ||
| Total Depreciation and Amortization | -3.88% | 2.49% | 9.87% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -51.16% | 142.39% | 136.82% | ||
| Change in Net Operating Assets | -5.14% | -122.44% | 272.40% | ||
| Cash from Operations | 44.54% | -77.09% | 50.21% | ||
| Capital Expenditure | -38.66% | 33.85% | -108.87% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 61.06% | -1,577.59% | 155.24% | ||
| Cash from Investing | 59.23% | -2,681.30% | 129.01% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -34.42% | 11.90% | -48.62% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -34.42% | 11.90% | -48.62% | ||
| Foreign Exchange rate Adjustments | 91.83% | -164.38% | 274.21% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 76.93% | -227.90% | 97.45% | ||